Skip to main content
Equibles
NVCR logo

NVCR · NovoCure Ltd

Track NVCR — free

Use NVCR with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$17.94 +0.30 (+1.70%) At close · Sep 4
Russell 2000 member Rebalance outlook locked
Market Cap
$2.09B
Shares
116.45M

NVCR metrics

72 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$17.94
Market cap
$2.09B

Price action

19 metrics
Price change (1W)
+0.7%
Price change (30D)
+9.5%
Price change (3M)
+4.5%
Price change (6M)
+37.6%
Price change (YTD)
+38.7%
Price change (1Y)
+49.7%
Trailing year
Price change (5Y)
-87.1%
52-week high
$19.99
52-week low
$10.03
Change from 52-week high
-10.3%
Change from 52-week low
+78.9%
Annualized volatility
80.0%
Beta
1.6
RSI (14D)
55.7
Price vs SMA 50
+6.8%
Price vs SMA 200
+25.0%
Avg volume (3M)
1.59M
Relative volume
0.5
Average dollar volume
$26.77M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
116.45M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
3.0×
reciprocal yield 33.5%
P / book
6.2
reciprocal yield 16.2%
FCF yield
-1.2%
TTM · current market cap
Buyback yield
0.0%
P / FCF
—
P / operating cash flow
—
Earnings yield
-7.1%

Historical valuation

8 metrics
P / E historical average (3Y)
933.0×
reciprocal yield 0.1%
P / E historical average (5Y)
933.0×
reciprocal yield 0.1%
EV / revenue historical average (3Y)
9.8×
reciprocal yield 10.2%
EV / revenue historical average (5Y)
15.0×
reciprocal yield 6.7%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
2,613.9×
reciprocal yield 0.0%
EV / EBITDA historical average (5Y)
2,613.9×
reciprocal yield 0.0%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-23

Profitability

9 metrics
Gross margin
76.1%
Operating margin
-22.1%
Trailing 12 months
Net margin
-21.2%
Gross profit (TTM)
$532.27M
Operating profit (TTM)
−$154.40M
Net income (TTM)
−$148.56M
Trailing 12 months
Diluted EPS (TTM)
$-1.30
FCF margin
-3.6%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$7.29

Growth

11 metrics
Revenue growth YoY
+15.6%
Year over year
Net income growth YoY
—
Revenue (TTM)
$699.19M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+4.0%
Year over year · more shares
Revenue CAGR (3Y)
+6.8%
Revenue CAGR (5Y)
+5.8%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-43.9%
Return on assets
-18.7%
Debt / equity
—
Current ratio
2.9
EBITDA (TTM)
−$138.08M
Free cash flow (TTM)
−$25.43M
Quick ratio
2.7
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$93.70M
Total assets
$795.19M
Total debt
$195.05M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$2.81M
Capital expenditures (TTM)
$22.62M
R&D (TTM)
$224.72M
SG&A (TTM)
—
Stock compensation (TTM)
$129.16M
R&D / revenue
32.1%
Stock compensation / revenue
18.5%

Ownership (13F)

3 metrics
13F filers
217
13F filer change QoQ
-8
Institutional ownership
89.7%

Short interest

3 metrics
Short interest
7.9%
Latest settlement · 8.4 days to cover
Days to cover
8.4d
Short-squeeze score
78 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1645113 CUSIP G6674U108 13F (30d) 154 filings 154 filers Visit website Investor relations